What
image
  • imageAdvertising & Marketing
  • imageAutomotive
  • imageBusiness Dealerships
  • imageBusiness Services
  • imageEducation
  • imageFood & Beverage
  • imageHealth & Beauty
  • imageHome Based
  • imageHome Services
  • imageOthers
  • imagePet
  • imageRetail
  • imageTravel & Leisure
Where
image
image
At a glance
10K - 50K
Investment Range
501 - 1,000
Franchise Count
101 - 500 sq.ft
Area Required
6 - 12 months
Payback Period
16
Years in Franchising

About the brand

Misha Biotech Franchise

Brand & Franchise Snapshot

Brand Name Misha Biotech
Industry / Business Category Healthcare Products / Pharmaceuticals
Founded Year 2009
Franchise Started Year Not specified
Total Franchise Outlets 500–1000
Estimated Investment INR 10,000–50,000
Franchise Fee Not specified (typically covers brand access and initial stock)
Royalty Fee Not specified (often based on turnover in pharma franchises)
Space Requirement 100–200 sq.ft
Staff Requirement Typically 1–2 trained personnel for outlet operations
Expected Payback Period 6–8 months

1. What is Misha Biotech?

Misha Biotech is an Indian pharmaceutical company specializing in the formulation, development, and distribution of tablets, capsules, syrups, dry syrups, and oral suspensions. The brand serves healthcare providers, pharmacies, and end consumers, operating within the healthcare products franchise category. It provides a franchise model enabling partners to distribute or sell pharmaceutical products in urban and semi-urban markets.

2. How the Business Works

Franchise outlets act as distribution and retail points for Misha Biotech products:

  • Customers, primarily pharmacies or clinics, place orders for required formulations
  • Franchisees manage local inventory, maintain stock, and handle distribution logistics
  • Revenue is generated through wholesale or retail sales of pharmaceutical products
  • Operational workflow involves order management, delivery coordination, and compliance reporting

3. Products or Services Offered

Pharmaceutical Tablets antibiotics, analgesics, antipyretics, anti-inflammatories, multivitamins
Capsules soft gels, hard gelatin capsules in multiple therapeutic categories
Syrups pediatric and adult cough syrups, tonics, digestive aids
Dry Syrups pediatric antibiotic, anti-allergic, and antipyretic formulations
Oral Suspensions precise dosing solutions for children and elderly patients

4. Franchise Structure and Operating Model

Role of Franchise Partner manage local distribution, sales, and customer service for healthcare clients
Operational Responsibilities stock management, order fulfillment, customer support, regulatory compliance adherence
Franchisor-Franchisee Interaction provides product supply, training, marketing materials, and operational guidance
Outlet Operations franchisee ensures timely delivery, accurate record-keeping, and compliance with pharma regulations

5. Franchise Cost and Investment

Estimated Investment INR 10,000–50,000
Franchise Fee usually covers brand licensing and initial stock allocation
Setup Costs shelving, storage, basic office equipment, and initial inventory
Royalty Payments typically structured as a percentage of turnover or fixed fee; exact data not disclosed

6. Space and Setup Requirements

Space 100–200 sq.ft. suitable for storing and displaying products
Preferred Locations near pharmacies, clinics, or health hubs in urban/semi-urban areas
Equipment Needs storage racks, cabinets, order processing tools
Staffing Considerations one or two trained personnel for handling orders, customer service, and inventory management

7. Training and Franchise Support

Operational Training product knowledge, compliance requirements, customer service
Launch Assistance inventory setup, local market introduction
Marketing Support promotional materials, product catalogs, seasonal campaigns
Supply Chain Systems access to centrally managed product distribution
Ongoing Guidance updates on new formulations, regulatory compliance, and sales optimization

8. Revenue Model and ROI Factors

Revenue is primarily generated through sales to pharmacies, clinics, and healthcare providers:

  • Pricing depends on product type and market rates
  • Demand is driven by essential medicines and daily pharmaceutical needs
  • Repeat purchase potential is high due to recurring requirements in healthcare
  • Operational costs are low relative to revenue, enabling payback within 6–8 months

9. Brand Background and Expansion

Established Year 2009
Franchise Network 500–1000 outlets across India
Geographic Presence urban and semi-urban healthcare markets
Expansion Strategy increasing penetration in underserved regions while expanding product range

10. What Makes This Franchise Different

Misha Biotech distinguishes itself through a comprehensive pharmaceutical portfolio with high compliance standards, enabling franchisees to sell products that meet WHO-GMP and ISO norms. The combination of low setup space, recurring demand, and robust supply chain support allows rapid market entry and steady revenue streams.

11. Key Advantages of the Franchise

  • Large market demand for essential medicines
  • Scalable franchise model with low initial investment
  • Repeat customer potential through recurring pharma orders
  • Operational support including training and supply chain management
  • Expansion potential in urban and semi-urban regions

12. Who Should Consider This Franchise

  • Entrepreneurs seeking low-space, high-demand retail or distribution business
  • Experienced pharma distributors or professionals
  • Investors targeting recurring revenue in healthcare
  • Individuals interested in healthcare services and essential medicines

14. Similar Franchise Opportunities

  • Sun Pharma Franchise
  • Cipla PCD Pharma
  • Lupin Pharmaceuticals
  • GlaxoSmithKline Pharma
  • Macleods Pharmaceuticals

These companies operate in the pharmaceutical franchise sector, offering scalable distribution models for healthcare products.

Health & Beauty Healthcare Products B2C Semi-Absentee Individual

Investment and financials

Cost overview
Investment range10K - 50K
Franchise / Brand feeAvailable on inquiry
Royalty / CommissionAvailable on inquiry
Investment tierLow
Area required101 - 500 sq.ft
Staff required1 - 4
Setup complexitySimple
Renewal availableYes
Returns outlook
Expected monthly revenue
Available on inquiry
Revenue levelLow
Business modelB2C
Capital payback6 - 12 months
Capital sensitivityVery High

Investor fit profile

Operations
Operation modeSemi-Absentee
Location typeAny
Home-based possibleYes
Can run part-timeYes
Primary customerIndividual
Market characteristics
SeasonalityHigh
Recession resistanceHigh
Digital integrationHigh
Years in franchising16 years
Avg units / year46.9
Expansion velocityAggressive
Ideal for
Homemaker Student Salaried Professional seeking side income Health enthusiast

Franchise support

Training and agreement details
Renewal available
Yes

Brand strength

16
Years Franchising
46.9
Avg Units / Year
2009
Founded
A
Brand Tier
A
Tier A — Mature brand
A+Established AMature BGrowing CStartup
Mature Aggressive

Forefind rank history

#2#3#4#5#62020202120222023202420252020: #42021: #42022: #42023: #42024: #42025: #4
Current rank
#4
#4 of 168 in Healthcare Products
2025
Rank stable since 2020
Based on Forefind scoring model

Licences and compliance

Required licences and registrations for operating this franchise in India. Requirements may vary by state and city tier.
Drug License if OTC
FSSAI if nutraceuticals
Setup complexity: Simple

Frequently asked questions

Investment ranges from INR 10,000 to 50,000, covering initial inventory, minimal setup, and brand access.

Franchisees manage local distribution, sales, and stock for healthcare providers while adhering to brand and compliance guidelines.

100–200 sq.ft. of space is sufficient to store products and operate efficiently.

With high-demand pharmaceutical products, typical payback period is 6–8 months.

Prospective partners can contact Misha Biotech to secure franchise rights, receive training, and integrate with the supply network. ### 14. Similar Franchise Opportunities

Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.

image